Legal & General Group Plc - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$2,445,211
+52.1%
92,727
-0.8%
0.00%0.0%
Q2 2023$1,607,943
+12.0%
93,485
+8.0%
0.00%0.0%
Q1 2023$1,435,116
+126.7%
86,557
+4.2%
0.00%
Q4 2022$633,055
-22.4%
83,078
+1.3%
0.00%
Q3 2022$816,000
-17.0%
82,029
-24.2%
0.00%
Q2 2022$983,000
+14.2%
108,275
+27.7%
0.00%
Q1 2022$861,000
-39.8%
84,764
-1.2%
0.00%
Q4 2021$1,431,000
-61.7%
85,781
+7.5%
0.00%
-100.0%
Q3 2021$3,739,000
-8.0%
79,790
+19.7%
0.00%0.0%
Q2 2021$4,063,000
+10.9%
66,650
+12.0%
0.00%0.0%
Q1 2021$3,665,000
+4.7%
59,502
+20.9%
0.00%0.0%
Q4 2020$3,501,000
+124.4%
49,232
+18.4%
0.00%0.0%
Q3 2020$1,560,000
+164.4%
41,575
+129.2%
0.00%
Q2 2020$590,000
+90.3%
18,141
+58.0%
0.00%
Q1 2020$310,000
+98.7%
11,481
+158.3%
0.00%
Q4 2019$156,000
+95.0%
4,445
+19.7%
0.00%
Q3 2019$80,000
+3900.0%
3,714
+6532.1%
0.00%
Q2 2019$2,000560.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders